The role of ATF-2 in oncogenesis

Spiros A Vlahopoulos1, Stella Logotheti, Dimitris Mikas

  • 1Unit of Biomedical Applications, Institute of Biological Research and Biotechnology, National Hellenic Research Foundation, Athens, Greece.

Insights

Activating Transcription Factor-2 (ATF-2) has dual roles in cancer, potentially promoting or inhibiting tumor growth. This review explores ATF-2

Area of Science:

  • Molecular Biology
  • Oncology
  • Cellular Signaling

Background:

  • Activating Transcription Factor-2 (ATF-2) is a bZIP transcription factor with varied functions in mammalian cells.
  • ATF-2 regulates genes involved in cell proliferation, such as cyclin A, cyclin D, and c-jun, which are implicated in oncogenesis.
  • The role of ATF-2 in cancer is complex, with studies suggesting both pro-tumorigenic and anti-tumorigenic effects.

Purpose of the Study:

  • To review signaling pathways that activate ATF-2.
  • To summarize ATF-2's downstream targets and their role in oncogenesis.
  • To examine ATF-2's function in carcinogenesis and its potential as a target for anticancer drug design.

Main Methods:

  • Literature review of signaling pathways activating ATF-2.
  • Analysis of ATF-2 downstream targets, including cyclins and c-jun.
  • Examination of data from human cancer cell lines, tumors, and mouse models.

Main Results:

  • ATF-2 activation pathways and downstream targets involved in oncogenesis were identified.
  • Evidence suggests ATF-2 expression correlates with cancer cell phenotype maintenance.
  • Contrasting evidence indicates ATF-2 may also possess antiproliferative or apoptotic functions.

Conclusions:

  • ATF-2 plays a multifaceted role in carcinogenesis, influenced by cellular context and signaling.
  • A functional model for ATF-2 in carcinogenesis is proposed.
  • ATF-2 presents a potential target for novel anticancer therapeutic strategies.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...